Overview

Gabapentin as Adjunctive Treatment for Postoperative Pain Control

Status:
Completed
Trial end date:
2017-06-29
Target enrollment:
Participant gender:
Summary
The specific aims of this research study are to use 600 mg gabapentin as an adjunctive treatment for acute postoperative pain control in order to reduce postoperative opiate consumption and improve postoperative pain control.
Phase:
Phase 1
Details
Lead Sponsor:
Indiana University
Treatments:
Gabapentin
gamma-Aminobutyric Acid